Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Urology ; 153: 139-146, 2021 07.
Article in English | MEDLINE | ID: mdl-33482125

ABSTRACT

OBJECTIVE: To determine the effectiveness of 2 different continuous quality improvement interventions in an integrated community urology practice. We specifically assessed the impact of audited physician feedback on improving physicians' adoption of active surveillance for low-risk prostate cancer (CaP) and adherence to a prostate biopsy time-out intervention. MATERIALS AND METHODS: The electronic medical records of Genesis Healthcare Partners were analyzed between August 24, 2011 and September 30, 2020 to evaluate the performance of 2 quality interventions: audited physician feedback to improve active surveillance adoption in low-risk CaP patients, and audited physician feedback to promote adherence to an electronic medical records embedded prostate biopsy time-out template. Physician and Genesis Healthcare Partners group adherence to each quality initiative was compared before and after each intervention type using ANOVA testing. RESULTS: For active surveillance, we consistently saw an increase in active surveillance adoption for low risk CaP patients in association with continuous audited feedback (P < .001). Adherence to the prostate biopsy time-out template improved when audited feedback was provided (P < .001). CONCLUSION: The implementation of clinical guidelines into routine clinical practice remains challenging and poses an obstacle to the improvement of United States healthcare quality. Continuous quality improvement should be a dynamic process, and in our experience, audited feedback coupled with education is most effective.


Subject(s)
Biopsy , Practice Patterns, Physicians'/standards , Prostatic Neoplasms , Quality Improvement/organization & administration , Urology , Watchful Waiting , Biopsy/methods , Biopsy/standards , Clinical Audit/statistics & numerical data , Community Health Services/standards , Delivery of Health Care, Integrated/methods , Delivery of Health Care, Integrated/standards , Electronic Health Records/statistics & numerical data , Guideline Adherence , Humans , Male , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/epidemiology , Prostatic Neoplasms/pathology , Risk Assessment , United States/epidemiology , Urology/methods , Urology/organization & administration , Urology/standards , Watchful Waiting/methods , Watchful Waiting/standards
3.
Urol Pract ; 8(1): 47-52, 2021 Jan.
Article in English | MEDLINE | ID: mdl-37145430

ABSTRACT

INTRODUCTION: Clinical tumor staging is an important component of risk stratification, which is central in assessment and treatment of patients with prostate cancer. We evaluated the potential of an examination based tumor staging template embedded within the electronic medical record to improve consistency and clarity of clinical tumor staging. METHODS: We conducted a retrospective analysis before template implementation (January to March 2017), followed by prospective analysis after implementation (April to August 2017). Physicians were educated on use and importance of the staging template prior to implementation. Assessment of digital rectal examination clarity included confident-explicit (cT stage documented), confident-implicit (stage inexplicit, cT stage interpreted) and unconfident (inability to discern cT stage). Clarity and consistency of tumor staging before and after template implementation were compared using a chi-square test. RESULTS: A total of 573 biopsies were analyzed: 234 before template use (40%) and 339 after (60%). In men at risk for prostate cancer explicit staging increased from 16% to 60% (p <0.001) following implementation of the staging template. Overall staging (explicit plus implicit) increased (from 74% to 92%, p <0.001), while unconfident staging decreased (from 26% to 8%, p <0.001) after implementation. In men with positive biopsies (309) explicit staging increased (from 29% to 64%, p <0.001) and overall staging increased (from 76% to 92%, p <0.001), while unconfident staging decreased (from 24% to 8%, p <0.001). CONCLUSIONS: Accurate prostate cancer clinical staging is important in risk stratification and treatment. We demonstrate the ability of a standardized, electronic medical record embedded, American Joint Committee on Cancer based template to improve the consistency and clarity of clinical staging in prostate cancer.

SELECTION OF CITATIONS
SEARCH DETAIL
...